SEC Form 4 · accession 0001127602-17-012418
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & CEO · Director
Period of report
Mar 16, 2017
Accepted (ET)
Mar 20, 2017 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 16, 2017 | M | 1,218 | $30.75 | A | 1,358 | D | |
| Common StockF3 | Mar 16, 2017 | S | 318 | $138.2197 | D | 1,040 | D | |
| Common StockF4 | Mar 16, 2017 | S | 300 | $139.2666 | D | 740 | D | |
| Common StockF5 | Mar 16, 2017 | S | 300 | $140.6166 | D | 440 | D | |
| Common StockF6 | Mar 16, 2017 | S | 200 | $141.87 | D | 240 | D | |
| Common Stock | Mar 16, 2017 | S | 100 | $144.16 | D | 140 | D | |
| Common StockF2 | Mar 16, 2017 | M | 959 | $30.75 | A | 649,205 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2 | $30.75 | Mar 16, 2017 | M | 1,218 | D | Dec 26, 2009 | Dec 31, 2017 | Common Stock | 1,218 | 81,490 | D |
| Stock OptionsF2 | $30.75 | Mar 16, 2017 | M | 959 | D | Dec 26, 2009 | Dec 31, 2017 | Common Stock | 959 | 80,531 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. The transaction was structured as a broker-assisted cashless exercise, such that the number of shares sold was limited to a sufficient number to cover the exercise price of the options and anticipated taxes. The remaining shares are held by a trust beneficially owned by the reporting person.
- F2Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- F3This transaction was executed in multiple trades at prices ranging from $137.78 to $138.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $138.83 to $139.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $140.18 to $141.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $141.48 to $142.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.